UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 529

Sortiert nach

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

Annals of the rheumatic diseases, 2022-12, Vol.81 (12), p.1647

2022

Link zum Volltext

Verfügbarkeit prüfen

Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis

Annals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1624

2017

Link zum Volltext

Verfügbarkeit prüfen

Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica

Annals of the rheumatic diseases, 2023-11, Vol.83 (3), p.335

2023

Link zum Volltext

Verfügbarkeit prüfen

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia

Annals of the rheumatic diseases, 2020-03, Vol.79 (3), p.393

2020

Link zum Volltext

Verfügbarkeit prüfen

Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study

Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1388-1392

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

Annals of the rheumatic diseases, 2020-09, Vol.79 (9), p.1252

2020

Link zum Volltext

Verfügbarkeit prüfen

Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.993-997

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Annals of the rheumatic diseases, 2022-01, Vol.81 (1), p.124

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis

Annals of the rheumatic diseases, 2020-12, Vol.79 (12), p.1658

2020

Link zum Volltext

Verfügbarkeit prüfen

The incidence and characteristics of giant cell arteritis in Hispanics and the associated outcomes of ischemic ocular events and stroke

Journal of investigative medicine, 2023-04, Vol.71 (4), p.411-418

2023

Link zum Volltext

Verfügbarkeit prüfen

Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.235

2017

Link zum Volltext

Verfügbarkeit prüfen

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis

Annals of the rheumatic diseases, 2013-09, Vol.72 (9), p.1481-1487

2013

Link zum Volltext

Verfügbarkeit prüfen

Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses

Annals of the rheumatic diseases, 2019-07, Vol.78 (7), p.1012

2019

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis

Annals of the rheumatic diseases, 2016-08, Vol.75 (8), p.1527-1533

2016

Link zum Volltext

Verfügbarkeit prüfen

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis

Rheumatic & musculoskeletal diseases open, 2019-09, Vol.5 (2), p.e001020-e001020

2019

Link zum Volltext

Verfügbarkeit prüfen

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis

Rheumatic & musculoskeletal diseases open, 2019-09, Vol.5 (2), p.e001003-e001003

2019

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (6), p.1196-1202

2016

Link zum Volltext

Verfügbarkeit prüfen

Giant cell arteritis

BMJ (Online), 2019-05, Vol.365, p.l1964

2019

Link zum Volltext

Verfügbarkeit prüfen

What is the impact of giant cell arteritis on patients’ lives? A UK qualitative study

BMJ open, 2017-08, Vol.7 (8), p.e017073-e017073

2017

Link zum Volltext

Verfügbarkeit prüfen

Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden

Rheumatic & musculoskeletal diseases open, 2024-04, Vol.10 (2), p.e003960

2024

Link zum Volltext

Verfügbarkeit prüfen

IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis

Annals of the rheumatic diseases, 2013-02, Vol.72 (2), p.258-264

2013

Link zum Volltext

Verfügbarkeit prüfen

Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years

Rheumatic & musculoskeletal diseases open, 2024-02, Vol.10 (1), p.e003775

2024

Link zum Volltext

Verfügbarkeit prüfen

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases

Heart (British Cardiac Society), 2016-03, Vol.102 (5), p.383-389

2016

Link zum Volltext

Verfügbarkeit prüfen

Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis

Annals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1443

2019

Link zum Volltext

Verfügbarkeit prüfen

Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study

Rheumatic & musculoskeletal diseases open, 2023-01, Vol.9 (1), p.e002866

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 529

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(527)
Mit Volltextzugriff
(419)

Publikationsform

Artikel
(529)

Sprache

Englisch
(529)
Japanisch
(39)

Erscheinungsjahr

n.n

Thema

Humans
(495)
Life Sciences & Biomedicine
(418)
Science & Technology
(418)
Female
(265)
Rheumatology
(261)
Aged
(251)
Male
(198)
Giant Cell Arteritis
(191)
Giant Cell Arteritis - Complications
(180)
Biopsy
(158)
Middle Aged
(151)
Giant Cell Arteritis - Drug Therapy
(134)
Giant Cell Arteritis - Diagnosis
(112)
Patients
(112)
Vein & Artery Diseases
(112)
General & Internal Medicine
(110)
Medicine, General & Internal
(110)
Biological And Medical Sciences
(104)
Medical Sciences
(104)
Veins & Arteries
(100)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis

Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia

Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis

The incidence and characteristics of giant cell arteritis in Hispanics and the associated outcomes of ischemic ocular events and stroke

Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis

Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses

MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis

DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis

Giant cell arteritis

What is the impact of giant cell arteritis on patients’ lives? A UK qualitative study

Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden

IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis

Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases

Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis

Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study

Aktive Filter

Suchergebnisse filtern